Corporate Board Profile
Tech Score: 8/100
3 mention(s) identify DANIEL R. OMSTEAD, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| abrdn Life Sciences Investors | 2011-06-08 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry and has experience in biotech and pharmaceutical companies, indicating a strong technical background likely including programming skills. |
| abrdn Life Sciences Investors | 2021-04-13 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. | Dr. Omstead holds Ph.D. and Master's degrees in Chemical Engineering and Applied Chemistry, and has experience in biotech companies and research, indicating a strong technical background that likely includes programming skills. |
| abrdn Life Sciences Investors | 2022-04-12 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry, indicating a strong technical background; he has experience in biotech and pharmaceutical industries, which often involve technical and scientific expertise that may include programming skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2005-05-10 | DANIEL R. OMSTEAD, PH.D.* (51), 30 ROWES WHARF, BOSTON, MA 02110 President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003); ... * Trustee considered to be an "interested person" ... COMPENSATION TABLE ... Daniel R. Omstead, Ph.D. $0. |
| 2006-05-08 | Daniel R. Omstead, Ph.D. (52), President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003)... Compensation Table: $0 total compensation. |
| 2007-05-10 | Daniel R. Omstead, Ph.D. (53), 30 Rowes Wharf, Boston, MA 02110 President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; Director (since 2003) of Concentric Medical, Inc.; and Magellan Biosciences (since 2006). |
| 2008-05-05 | Daniel R. Omstead, Ph.D. (54), President of HQH and HQL; Interested Trustee; Total Compensation from both Funds and Fund Complex Paid to Trustees: $0. |
| 2009-05-01 | Daniel R. Omstead, Ph.D. (55), President of HQH and HQL; Interested Trustee; Compensation: $0 from both Funds. |
| 2010-04-27 | Daniel R. Omstead, Ph.D. (56), President, HQH and HQL; Interested Trustee; Compensation: $0 from both Funds. |
| 2011-06-08 | Dr. Omstead is President and Chief Executive Officer of Hambrecht & Quist Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to HQH and HQL. Dr. Omstead is also President of HQL and HQH. ... Compensation Table ... Daniel R. Omstead, Ph.D. ... Total Compensation ... $0 |
| 2012-04-30 | Daniel R. Omstead, Ph.D.: Dr. Omstead is President and Chief Executive Officer of Hambrecht & Quist Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to HQH and HQL. Dr. Omstead is also President of HQL and HQH. Dr. Omstead is portfolio manager for the public and restricted/venture portfolios within HQH and HQL. |
| 2013-04-25 | Daniel R. Omstead, Ph.D.: Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to HQH and HQL. Dr. Omstead is also President of HQH and HQL and serves on their Valuation Committee. ... Compensation Table For the fiscal year ended September 30, 2012 ... Daniel R. Omstead, Ph.D. $0 total compensation. |
| 2014-04-30 | Daniel R. Omstead, Ph.D.: Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to HQH and HQL. Dr. Omstead is also President of HQH and HQL and serves on their Valuation Committee. ... Compensation Table ... Daniel R. Omstead, Ph.D. ... Total Compensation ... $0. |
| 2015-04-20 | Daniel R. Omstead, Ph.D.* (61) 100 Federal Street, 19th Floor, Boston, MA 02110 Trustee, HQH, HQL and THQ; President, HQH and HQL (since 2001); President, THQ (since 2014); Member of each Fund's Valuation Committee. Compensation Table: Total Compensation from All Funds in Fund Complex Paid to Trustees $0. |
| 2016-04-18 | Daniel R. Omstead, Ph.D.: Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to HQH, HQL, THQ and THW. Dr. Omstead is also President of HQH, HQL, THQ and THW and serves on their Valuation Committee. |
| 2017-04-18 | Daniel R. Omstead, Ph.D.: Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to the Funds. Dr. Omstead is also President of the Funds and serves on their Valuation Committee. ... Compensation Table ... Daniel R. Omstead, Ph.D. ... Total Compensation from All Funds in Fund Complex Paid to Trustees $0. |
| 2018-04-18 | Daniel R. Omstead, Ph.D.: Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to the Funds. Dr. Omstead is also President of the Funds and serves on their Valuation Committee. Dr. Omstead is portfolio manager for the public and restricted/venture portfolios within the Funds. |
| 2020-04-14 | Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to the Funds. ... Dr. Omstead provides each Fund with insights into both pharmaceutical and biotech companies. ... Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. ... For the fiscal year ended September 30, 2019, the Independent Trustees as a group received $515 from HQH, $238 from HQL, $450 from THQ and $234 from THW for reimbursed expenses. ... Daniel R. Omstead, Ph.D. total compensation $0. |
| 2021-04-13 | Daniel R. Omstead, Ph.D.: Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC... He serves on their Valuation Committee. Compensation Table shows Daniel R. Omstead total compensation from all funds as $0. |
| 2022-04-12 | Daniel R. Omstead, Ph.D.: Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC and President of the Funds. He serves on their Valuation Committee. For the fiscal year ended September 30, 2021, his total compensation from the Funds was $0. |
| 2023-04-11 | Dr. Omstead is President and Chief Executive Officer of Tekla Capital Management LLC, a registered investment adviser that serves as investment adviser to the Funds. Dr. Omstead is also President of the Funds and serves on their Valuation Committee. For the fiscal year ended September 30, 2022, the Independent Trustees as a group received $2,098 from HQH, $2,037 from THQ and $1,140 from THW for reimbursed expenses. The following table sets forth information regarding compensation of the Trustees and Executive Officer by each Fund for the fiscal year ended September 30, 2022... Daniel R. Omstead, Ph.D. $0 total compensation. |
| Filing Date | Source Excerpt |
|---|---|
| 2005-05-10 | President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; President and Chief Executive Officer (from 1998-2000) of Reprogenesis, Inc. |
| 2006-05-08 | President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; Director (since 2003) of Concentric Medical, Inc.; President and Chief Executive Officer (from 1998-2000) of Reprogenesis, Inc. |
| 2007-05-10 | Daniel R. Omstead, Ph.D. (53), 30 Rowes Wharf, Boston, MA 02110 President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; Director (since 2003) of Concentric Medical, Inc.; and Magellan Biosciences (since 2006). |
| 2008-05-05 | Daniel R. Omstead, Ph.D. President of HQH and HQL (since 2001); Trustee of HQH and HQL (since 2003); President, Chief Executive Officer and Managing Member of Hambrecht & Quist Capital Management LLC; Director of Magellan Biosciences, Inc. (since 2006). |
| 2009-05-01 | President, Chief Executive Officer and Managing Member of Hambrecht & Quist Capital Management LLC (since 2002); Director of Magellan Biosciences, Inc. (since 2006); Director of Elemé Medical, Inc. (since 2008); Director of Concentric Medical, Inc. (2003-2007; 2008-present) |
| 2010-04-27 | Trustee, HQH and HQL (since 2003); President, HQH and HQL (since 2001); President, Chief Executive Officer and Managing Member, Hambrecht & Quist Capital Management LLC (since 2002); Director, Magellan Biosciences, Inc. (since 2006); Director, Elemé Medical, Inc. (since 2008); Director, Concentric Medical, Inc. (2003-2007; 2008-present); Director, Palyon Medical Corporation (since 2009). |
| 2011-03-30 | Daniel R. Omstead Ph.D serves as President and Chief Executive Officer of the Adviser. The address for Dr. Omstead is c/o the Adviser at 2 Liberty Square, 9th Floor, Boston, MA 02109. |
| 2011-06-08 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2012-04-30 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2013-04-25 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2014-04-30 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He has been President and CEO of biotech companies and is President and CEO of Tekla Capital Management LLC. |
| 2015-04-20 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He was President and CEO of biotech companies and is President and CEO of Tekla Capital Management LLC. |
| 2016-04-18 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2017-04-18 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2020-04-14 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University... Prior to entering the biotech industry, Dr. Omstead was employed for fourteen years in positions of increasing responsibility within the pharmaceutical industry. |
| 2021-04-13 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2022-04-12 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2023-04-11 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
Data sourced from SEC filings. Last updated: 2025-12-06